The vaccine rollout in the United States has been sluggish, hampered by manufacturing delays, logistical challenges, and freak snowstorms. Demand far outstrips supply. Meanwhile, the more transmissible variant circulating widely in the UK is gaining a foothold in the US. Modeling by the Centers for Disease Control and Prevention suggests it will quickly become the…
Read More
